About the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. Session
Hereditary cancers result from genetic mutations passed through families, increasing susceptibility to certain cancer types. BRCA1 and BRCA2 mutations are strongly associated with breast, ovarian, and pancreatic cancers, with targeted therapies like PARP inhibitors showing promise. Lynch syndrome-related cancers, including colorectal and endometrial cancers, are addressed through genetic counseling, regular screenings, and immunotherapy options. Research in hereditary cancers prioritizes identifying mutation carriers, understanding gene-environment interactions, and developing prevention strategies. The integration of genetic testing into clinical practice aids in early detection and personalized treatment planning.
Topics Covered in Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers.
BRCA Carrier Management
Mismatch Repair Deficiency
PARP Inhibitor Therapy
Cascade Family Testing
Prophylactic Surgery
Colonoscopic Surveillance
Related Scientific Sessions at CIOC 2027
Why Attend the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. Conference 2027 — FAQs
What is the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. track at CIOC 2027?
The Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. sessions?
Cancer researchers and clinicians, educators and students with an interest in Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. are all welcome — whether presenting or attending.
Can I present my research in the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.